ARCHIVES

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

This article is from The Cancer Letter archive.

Vol. 06 No. 40 | October 10, 1980

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

NCI-Approved Clinical Trials

July 28, 2006

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988